X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs FULFORD INDIA - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD FULFORD INDIA BIOCON LTD/
FULFORD INDIA
 
P/E (TTM) x 95.5 398.8 23.9% View Chart
P/BV x 7.8 6.2 125.4% View Chart
Dividend Yield % 0.2 0.1 187.9%  

Financials

 BIOCON LTD   FULFORD INDIA
EQUITY SHARE DATA
    BIOCON LTD
Mar-17
FULFORD INDIA
Mar-14
BIOCON LTD/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs1,162942 123.3%   
Low Rs483450 107.2%   
Sales per share (Unadj.) Rs194.6691.4 28.1%  
Earnings per share (Unadj.) Rs34.411.5 300.2%  
Cash flow per share (Unadj.) Rs48.315.4 314.2%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.10.3 42.3%  
Book value per share (Unadj.) Rs241.9380.0 63.7%  
Shares outstanding (eoy) m200.003.90 5,128.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.21.0 419.8%   
Avg P/E ratio x23.960.7 39.4%  
P/CF ratio (eoy) x17.045.3 37.6%  
Price / Book Value ratio x3.41.8 185.6%  
Dividend payout %2.917.4 16.7%   
Avg Mkt Cap Rs m164,4402,714 6,058.1%   
No. of employees `0009.20.4 2,079.7%   
Total wages/salary Rs m7,470505 1,479.2%   
Avg. sales/employee Rs Th4,213.96,073.0 69.4%   
Avg. wages/employee Rs Th809.01,137.4 71.1%   
Avg. net profit/employee Rs Th745.2100.7 740.2%   
INCOME DATA
Net Sales Rs m38,9112,696 1,443.1%  
Other income Rs m1,571125 1,252.8%   
Total revenues Rs m40,4822,822 1,434.6%   
Gross profit Rs m9,795-46 -21,109.9%  
Depreciation Rs m2,77215 18,236.8%   
Interest Rs m26010 2,736.8%   
Profit before tax Rs m8,33454 15,348.1%   
Minority Interest Rs m1630-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,61610 16,833.3%   
Profit after tax Rs m6,88145 15,393.7%  
Gross profit margin %25.2-1.7 -1,462.8%  
Effective tax rate %19.417.7 109.7%   
Net profit margin %17.71.7 1,066.7%  
BALANCE SHEET DATA
Current assets Rs m40,4771,738 2,328.5%   
Current liabilities Rs m16,783545 3,081.1%   
Net working cap to sales %60.944.3 137.6%  
Current ratio x2.43.2 75.6%  
Inventory Days Days6048 123.0%  
Debtors Days Days834 1,924.6%  
Net fixed assets Rs m45,07312 378,764.7%   
Share capital Rs m1,00039 2,564.1%   
"Free" reserves Rs m47,3771,443 3,283.2%   
Net worth Rs m48,3771,482 3,264.3%   
Long term debt Rs m21,0820-   
Total assets Rs m93,9422,077 4,523.6%  
Interest coverage x33.16.7 492.2%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.41.3 31.9%   
Return on assets %7.62.6 291.3%  
Return on equity %14.23.0 471.6%  
Return on capital %12.64.3 292.9%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m12,98817 75,511.6%   
Fx outflow Rs m7,899673 1,173.4%   
Net fx Rs m5,089-656 -775.8%   
CASH FLOW
From Operations Rs m6,40090 7,111.1%  
From Investments Rs m-4,985105 -4,765.8%  
From Financial Activity Rs m-1,775-14 12,588.7%  
Net Cashflow Rs m-473181 -262.0%  

Share Holding

Indian Promoters % 40.4 0.0 -  
Foreign collaborators % 20.6 75.0 27.5%  
Indian inst/Mut Fund % 8.4 3.8 221.1%  
FIIs % 10.7 0.1 10,700.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 21.2 93.9%  
Shareholders   109,995 4,783 2,299.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  

Compare BIOCON LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Jun 22, 2018 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE BIOCON LTD WITH

MARKET STATS